Annual Congress Vienna 2003

Citations should be made in the following way: Authors. Title. Eur Respir J 2003; 22: Suppl. 45, abstract number.

Material from 2003:

Material from 2003: Show

Oral Presentation
Chairs: N. Schoenfeld (Berlin, Germany), S. G. Spiro (London, United Kingdom)

Influence of department of health guidelines on ²urgent referral² and 2 week wait (2WW) initiative on referrals for a suspected diagnosis of lung cancer N. R. Lewis, I. R. LeJeune, D. R. Baldwin (Nottingham, United Kingdom)
The delays due to patient‘s and doctors‘ in non- small cell lung cancer patients E. Radzikowska, P. Glaz, K. Roszkowski (Warsaw, Poland)
Quality of life in lung cancer: does disclosing of the diagnosis have an impact? M. Lheureux, C. Raherison, J. M. Vernejoux, M. Tunon de Lara, A. Taytard (Pessac, France)
Vascular endothelial growth factor (VEGF) expression in non small cell lung cancer and its association with histopathologic type, stage, lymphnode involvement, recurrence and distant metastasis D. Ernam, A. Yilmaz, F. Atalay, S. Atikcan, I. Tastepe, F. Demirag, E. Unsal (Ankara, Turkey)
The clinical significance of CD40 molecule expressed on human lung cancer J. A. Huang, T. L. Wang, Y. M. Zhuang, Y. B. Zhu, T. Gu, Q. Shi, X. G. Zhang (Suzhou, China)
Microvessels invasion in resected N0 locally advanced NSCLC A. Akopov, I. V. Dvorakovskaya, V. Egorov (St Petersburg, Russia)
The clinical significance of serum interleukin 18 concentration in lung cancer W. Naumnik, E. Chyczewska, T. Izycki, J. Talalaj (Bialystok, Poland)
Clinical and prognostic significance of autoantibodies against recoverin in non small cell lung cancer O. N. Shifrina, A. V. Bazhin, M. S. Savchenko, P. P. Philippov, A. G. Chuchalin (Moscow, Russia)